17:12 , May 17, 2019 |  BC Extra  |  Financial News

Tools4Patient raises €4M to refine, expand placebo response analytics

As it seeks to apply its placebo response measurement tool to new therapeutic areas beyond pain, Tools4Patient has tapped investors for a €4 million ($4.5 million) series B round. The company's Placebell technology uses an...
07:00 , Jun 30, 2014 |  BC Week In Review  |  Company News

Beth Israel Deaconess, Biometheus deal

Newco Biometheus emerged from stealth mode and announced an exclusive option from Beth Israel Deaconess Medical Center to IP covering technology to detect placebo responders. Biometheus is developing a PCR-based test that detects a polymorphism...
07:00 , Jun 30, 2014 |  BioCentury  |  Emerging Company Profile

Biometheus: Placebo parity

Biometheus LLC has a biomarker for a polymorphism that can prospectively identify patients who will respond to placebo in clinical trials. The marker could allow companies to exclude these patients up front and cut trial...
01:02 , Jun 24, 2014 |  BC Extra  |  Company News

Biometheus debuts to screen placebo responders

Newco Biometheus LLC (Cambridge, Mass.) emerged from stealth mode on Monday and announced an exclusive option from Beth Israel Deaconess Medical Center to IP covering technology to detect placebo responders. Biometheus is developing a PCR-based...